Projects per year
- 1 - 50 out of 1,428 results
Search results
-
?Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response?
9/19/23 → 8/31/28
Project: Federal Funding Agencies
-
(PQA4) Affordable Test of the Exposure to Hepatocellular Carcinoma Risk by V-Chip
Qin, L.
9/10/13 → 6/30/18
Project: Federal Funding Agencies
-
(PQD-5) Patient Derived Orthotopic Xenograft Models for Drug Response Prediction
5/15/14 → 4/30/18
Project: Federal Funding Agencies
-
18F-MK-6240 Tau PET and Brain Inflammation in Alzheimer’s Disease
Masdeu, J. C., Faridar, A., Fujita, M., Nakawah, M. O., Pascual, B. & Roman, G. C.
10/29/19 → …
Project: Clinical Trial
-
18th International Workshop on Ataxia-Telangiectasia and ATM to be held at The Houston Methodist Research Institute
8/1/18 → 7/31/19
Project: Federal Funding Agencies
-
-
2009-030442-001 Tuberculosis Elimination
Texas Dept of State Health Services
12/12/08 → 9/30/11
Project: Federal Funding Agencies
-
-
-
2023 ACS Prevention & Screening Project Recruitment Colon Cancer
1/1/23 → 12/31/23
Project: Non Profit
-
3D printed biomaterial encapsulation with localized immunomodulation for islet transplantation
Grattoni, A., Li, X. C. & Gaber, A. O.
3/1/18 → 2/28/20
Project: Non Profit
-
-
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
8/1/23 → 7/31/30
Project: Federal Funding Agencies
-
4-aminopyridine promotes extensive recovery in acute spinal cord injury
7/1/17 → 6/30/21
Project: Federal Funding Agencies
-
6th Annual International Conference in Computational Surgery and Dual Training - Travel Grant
2/1/16 → 1/31/17
Project: Federal Funding Agencies
-
-
A bifunctional nanomedicine for both specific imaging and targeting therapy of an
6/17/10 → 4/30/16
Project: Federal Funding Agencies
-
-
A CRISPR-C2c2 based system to target toxic RNA in myotonic dystrophy type 1
3/29/18 → 9/28/19
Project: Non Profit
-
Activatable one-drop and one-step assay for circulating tumor cell detection
9/18/12 → 8/31/16
Project: Federal Funding Agencies
-
A Culturally Targeted Transplant Program to Increase Live Donation in Hispanics
Gaber, A. O. & Gordon Burroughs, S.
3/20/16 → 2/28/21
Project: Federal Funding Agencies
-
Acupuncture Trial
Niravath, P. A., Chang, J. C., Heyne, K., Mai, H. P., Singh, M. & Sun, K.
Project: Clinical Trial
-
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
Kleiman, N., Faza, N., Goel, S., Little, S. H., Reardon, M. J. & Volpi, J. J.
9/9/19 → …
Project: Clinical Trial
-
Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter - Directed Thrombolysis-ATTRACT Trial
2/26/10 → 3/31/11
Project: Federal Funding Agencies
-
-
-
Administrative supplement for rapid advancement of a safe and effective vaccine targeting Monkeypox
9/30/22 → 9/29/24
Project: Federal Funding Agencies
-
A DNAzyme that targets the CAG repeat RNA in polyglutamine diseases
3/1/20 → 2/28/21
Project: Non Profit
-
Advancing Human Lung Microphysiological Systems to Model Coronavirus Infection and Test Candidate Countermeasures
10/14/22 → 3/22/24
Project: Federal Funding Agencies
-
Advancing MRI Technology for Early Diagnosis of Liver Metastases
12/1/20 → 11/30/24
Project: Federal Funding Agencies
-
AFINITI-An Augmented System for Neuroimaging Followup
9/30/07 → 3/30/12
Project: Federal Funding Agencies
-
African trypanosome parasites: a new tool to unveil potential immunological strategies totarget CLL
5/3/21 → 4/30/24
Project: Federal Funding Agencies
-
Age-related mild cognitive impairment and the protective role of Glutathione: implications for Alzheimerâ??s disease
9/15/17 → 5/31/22
Project: Federal Funding Agencies
-
Age-related TDP-43 neuropathology: using disease-driving mechanisms to guide classification
9/15/20 → 3/31/24
Project: Federal Funding Agencies
-
A GMP/GLP investigation of degradable polymeric shells for traumatic osteoregeneration
Taraballi, F., Ihrig, M. & Weiner, B. K.
9/30/15 → 9/29/24
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
9/30/19 → 5/31/24
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
6/1/19 → 4/30/24
Project: Federal Funding Agencies
-
-